VEGFA and hemorrhage: A multivariate analysis was conducted to identify which factors affected the final BCVA, including age, baseline BCVA, thickness (T0 or T1+T3) and size (S1 or S2+S3) of SMH, layers involved in the hemorrhage (L0 or L1–4, L1 or L2–4, L1 or L2+3), baseline diseases (tnAMD, PCV, or RAM), duration from onset to intervention (AO or A1+A2), treatment or no treatment with PPV, and with or without anti-VEGF therapy after treatment (Table 4).